Skip to content

Diagnostic Imaging Aid for Management of Cervical Lesions

Development and Application of a Diagnostic Imaging Aid for One-visit Management of Cervical Lesions in Low-resource Settings

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02406365
Acronym
FFC
Enrollment
618
Registered
2015-04-02
Start date
2015-04-30
Completion date
2017-12-31
Last updated
2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Cervical Intraepithelial Neoplasias, Digital Colposcopy, Precancerous Cervical Lesions

Brief summary

A handheld digital colposcope which utilizes flurorescent light is being tested for the rapid detection and management of cervical lesions. The handheld research device captures cervical images which with the fluorescent light show the regions of cervical tissue that autofluoresce. The investigators will study the relationship between the level of fluorescence and the samples of tissue (biopsies) obtained from the patient as part of her routine care. The investigators will also compare the efficacy of the hand held device with the data being collected from the other research devices being tested by the team, i.e. the multispectral digital colposcopes.

Interventions

DEVICEDiagnostic imaging aid for one-visit management of cervical lesions

Sponsors

Brookdale University Hospital Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women who are at least 18 years old * Women who are not pregnant as confirmed by a urine test * Women who are not breastfeeding * Women who understand the study procedures and can provide written informed consent

Exclusion criteria

* Women who do not meet the inclusion criteria * Women who have had a hysterectomy

Design outcomes

Primary

MeasureTime frameDescription
Detection of precancerous cervical lesions or cervical cancerAt point of care for colposcopy or treatment with LEEP (5 minutes).Eligible patients who are referred to the colposcopy clinic for a diagnosis following an abnormal Pap smear will be asked to participate in the study. All participating women will receive their standard of care colposcopy as usual. In addition to their routine care, the handheld imaging research device will also be used to capture cervical images. The images will be analyzed and compared to the biopsies obtained. The imaging device will not be used to make a diagnosis. As part of the research study, one or two additional biopsies will be obtained if the patient agrees. These additional biopsies will serve as the control tissue, since they will be taken from tissue that appears normal through the colposcope.

Countries

United States

Contacts

Primary ContactLeonid Fradkin, PhD
lfradkin@bhmcny.org718-240-8225
Backup ContactThelma Carrillo, MPH
tcarrill@bhmcny.org718-240-5978

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026